Novavax, Serum Institute seek DCGI emergency use nod for recombinant nanoparticle COVID vaccine Medical Dialogues Team7 Aug 2021 11:30 AM ISTNew Delhi: Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of...
CoronaVac COVID-19 vaccine found safe and effective in interim analysis: Lancet Hina Zahid12 July 2021 9:00 AM ISTInterim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against...
Submit results on adult trials first: Govt panel to Serum Institute on Covavax trials for children Ruchika Sharma2 July 2021 12:00 PM ISTNew Delhi: An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct...
First batch of COVID vaccine Covovax being manufactured at Pune facility: Serum Institute CEO Ruchika Sharma26 Jun 2021 9:00 AM ISTPune: The first batch of Covovax, a COVID-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility,...
Serum Institute eyes launching Covavax in India by September: Report Ruchika Sharma18 Jun 2021 12:15 PM ISTNew Delhi: The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September...
Novavax COVID-19 vaccine shows 90 pc efficacy and 100 pc protection: PREVENT-19 trial Hina Zahid15 Jun 2021 12:04 PM ISTPREVENT-19 confirms that NVX-CoV2373 offers a reassuring tolerability and safety profile. Novavax's protein-based COVID-19 vaccine, NVX-CoV2373...
Covid-19: With DCGI nod to revised protocol, Covovax Phase 3 trial to proceed without placebo Medical Dialogues Team7 Jun 2021 5:44 PM ISTPune: In a significant advance to the Serum Institute of India (SII), the Drugs Controller General of India (DCGI) has given its nod to approve the...
Novavax Covid-19 vaccine shows 43 percent efficacy against South African variant Ruchika Sharma8 May 2021 2:25 PM ISTNew Delhi: Novavax Inc's Covid-19 vaccine had efficacy of 43% against infections caused by the South African variant in a group that included people...
Supply shortages delaying full-speed production of COVID-19 vaccine: Novavax Ruchika Sharma14 April 2021 2:57 PM ISTNew Delhi: Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third...
India to have 5 more COVID vaccines by Oct Ruchika Sharma12 April 2021 12:02 PM ISTThese vaccines are Sputnik V vaccine, Johnson and Johnson vaccine, Novavax vaccine, Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.
Serum Institute legally compelled to ship Covid-19 vaccine: COVAX Ruchika Sharma10 April 2021 12:56 PM ISTThe pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and...
Novavax begins COVID-19 vaccine clinical trial crossover Ruchika Sharma6 April 2021 1:30 PM ISTGaithersburg: Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, has recently announced the...
